Ovid Therapeutics sets 2025 Annual Meeting for July 9; shareholder proposal deadline May 12

Ovid Therapeutics Inc.

Annual Meeting scheduled for July 9, 2025; record date for voting is May 19, 2025.
Shareholder proposals under Rule 14a-8 must be received by May 12, 2025.
Director nominations and other proposals under bylaws also due by May 12, 2025.
Meeting delayed more than 30 days from 2024 anniversary, triggering this 8-K notice.
Stockholders intending to use universal proxy rules must provide Rule 14a-19 notice by May 12, 2025.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.